Navigation Links
Discovery Labs Reports First Quarter 2013 Financial Results
Date:5/7/2013

ement by the Company shall be required; however, the Warrants are classified as derivative liabilities in accordance with generally accepted accounting principles because they contain anti-dilution provisions that adjust the exercise price of the warrants in certain circumstances. 

The Company had 43.8 and 43.7 million shares of common stock outstanding as of March 31, 2013 and December 31, 2012, respectively.

Readers are referred to, and encouraged to read in their entirety the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 to be filed with the Securities and Exchange Commission, which includes further detail on the above-referenced transactions and the Company's business plans and operations, financial condition and results of operations.

ABOUT DISCOVERY LABS
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care.  Discovery Labs' novel proprietary KL4 surfactant technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant.  Discovery Labs is also developing its proprietary drug delivery technologies to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies.  Discovery Labs' strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants.  Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, significantly expand the current worldwide RDS market.

For more information, please visit the Company's website at www.Discoverylabs.com.

Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe harb
'/>"/>

SOURCE Discovery Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
2. Afraxis, Inc. and Servier Announce a Collaboration on ESP Platform for Drug Discovery in Central Nervous System Disorders
3. Kymab Announces Kymouse Antibody Discovery Agreement With Novo Nordisk
4. MetaStat Appoints David Epstein, Ph.D. as Advisor to Lead Drug Discovery
5. Family Tree DNAs Genomics Research Center Facilitates Discovery of Extremely Ancient Root to the Human Y Chromosome Phylogenetic Tree
6. Discovery Labs Reports Fourth Quarter 2012 Financial Results
7. E-Discovery Industry Veteran Joins VeDISCOVERY LLC
8. Innovative Research Collaboration to Advance Next-Generation Methods in Peptide Discovery for Cosmeceuticals
9. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
10. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
11. RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... July 27, 2015   Mallinckrodt plc ... company, announced today that it has entered into ... its global contrast media and delivery systems (CMDS) ... transaction valued at approximately $270 million.   ... is consistent with the company,s stated plan to ...
(Date:7/27/2015)... , July 20, 2015 ... addition of the "Global Pressure Relief Devices Market ... Global Pressure Relief Devices market to grow at a ... report, Global Pressure Relief Devices Market 2015-2019, has been ... from industry experts. The report covers the Americas, and ...
(Date:7/27/2015)... BOULDER, Colo. , July 27, 2015 ... will report financial results for the fourth ... and hold a conference call to discuss ... Ron Squarer, Chief Executive Officer will lead ... 2015Time:9:00 a.m. Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: ...
Breaking Medicine Technology:Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 2Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 3Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 4Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 5Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 6Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 7Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2
... will be able to share Thanksgiving and other holidays with ... safely and independently in the comfort of their own homes, ... Homecare also provides tremendous value to more than eight ... home, says the American Association for Homecare. Home medical equipment ...
... Nov. 23, 2011  Dune Medical Devices announced today ... President and Chief Financial Officer, effective immediately.  Mr. ... Financial Officer of Cadent, Inc. through Cadent,s acquisition ... addition, Mr. Blanchette has served in a variety ...
Cached Medicine Technology:The Holidays Highlight the Value of Home-Based Health Care 2The Holidays Highlight the Value of Home-Based Health Care 3Dune Medical Announces Appointment of Roger Blanchette as Chief Financial Officer 2
(Date:7/27/2015)... ... July 27, 2015 , ... In a piece published July ... of plastic surgery and explained why people should not shy away from their own ... excesses of the few and celebrate it for the modern wonder that it is.” ...
(Date:7/27/2015)... ... ... North Central Surgical Center Hospital will be holding twice-monthly joint wellness classes for ... along with their friends and family members, to attend. The classes take place on ... [Tue due to Labor Day], Oct 5, Nov 2, Dec 7) beginning at 9 ...
(Date:7/27/2015)... ... 27, 2015 , ... A Harris County jury awarded a group of Texas ... promoter Robert Kubbernus based on findings of fraud and violations of the Texas Securities ... court in Cause No. 2010-09675; Jo Ann Schermerhorn, et al v. CenturyLink, Inc. and ...
(Date:7/27/2015)... ... 2015 , ... BESLER Consulting today announced the publication of ... Medicare and Medicaid Services (CMS) provides each hospital affected by the HRRP with ... the QualityNet Hospital-Specific Report (HSR), this report contains a variety of insights that ...
(Date:7/27/2015)... ... 2015 , ... For a limited time, Huntington Beach dentist , Dr. ... a great time to change up a look or to simply brighten a smile. ... your self-esteem. Over time, the enamel coating can become worn and can expose more ...
Breaking Medicine News(10 mins):Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 3Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 4Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 5Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 6Health News:BESLER Consulting Publishes E-book Focused on Reducing Hospital Readmissions 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 3
... are known to be good for lowering cholesterol and ... reported benefit: they appear to slow decline in lung ... According to researchers in Boston, it may be statins ... , Their findings were published in the second issue ...
... hire an ad agency; at,least not initially especially if you ... an agency can,t come up with something great. It,s,just that ... Most clients follow tradition process in attempting to find ... develop a,short list of 3 agencies and ask for a ...
... Educate Chicagoans, CHICAGO, Oct. 11 Continuing ... of Chicago, SAVE THE PATIENT, a,not-for-profit patient-focused organization, ... Chicago Access Network. "Community Health Hotline" will,air Monday, ... 21., Monday,s program will feature a frank ...
... /Xinhua-PRNewswire/ -- On,October 10, 2007, Synutra International, Inc. ... dairy-based nutritional products,for infants, children and adults, received ... the Company,s common stock is no longer subject ... October 5, 2007 of the,Company,s quarterly report on ...
... Monday will be a little,cooler for the patients ... the entire Washington Capitals team will make their annual,visit. ... raise money for,cancer research, Courage Caps., Courage Caps ... the season at Capitals home games and online at ...
... who overcome breast cancer have every reason to celebrate. ... a heart damaged by life-saving cancer therapies, a growing ... today including new treatments still under development ... Jones, Ph.D., an exercise physiologist and assistant professor in ...
Cached Medicine News:Health News:Statins reduce loss of function, keeping old lungs young - even in smokers 2Health News:A New Way to Discover Marketing Ideas 2Health News:Patient Empowerment -- Medication Error 2Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:Breast cancer awareness calls for cardiovascular awareness 2Health News:Breast cancer awareness calls for cardiovascular awareness 3
... For delivery of medication as well as ... refillable, closed dilution, high volume, continuous medication ... therapy to patients. Its 200 ml reservoir ... to 8 hours of nebulized medication delivery ...
Nebulizer Adapter Kit 6"...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
Medicine Products: